Analgesics - Saudi Arabia | Statista Market Forecast

In Saudi Arabia, the revenue in the Analgesics market reached US$184.70m in 2024.
It is projected to experience an annual growth rate of 4.29% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue, amounting to US$7.24bn in 2024.
In terms of per capita figures, the revenue generated per person in Saudi Arabia amounts to US$4.93 in 2024.
Saudi Arabia is witnessing a growing demand for analgesics in the OTC Pharmaceuticals market due to an increasing prevalence of chronic conditions and a rising elderly population.

Definition:
The Analgesics market comprises over-the-counter natural and synthetic non-opioid analgesics (only in approved low doses) like Paracetamol, Ibuprofen, Aspirin, Diclofenac and other pain-relieving preparations. Legislation on opioid analgesics differs from country to country. According to the respective state legislation, legal opioid analgesics are included. In Germany, Austria and Switzerland, for instance, opioid analgesics are only included if they are not limited by the narcotics law and do not require prescription. Analgesics are included in the form of pills, capsules, gels and ointments. Not included are prescription medicines (e.g. morphine), anesthetics and homeopathic remedies. Among the top-selling painkillers are Voltaren, Aspirin, Thomapyrin, Ibuprofen, Dolormin, Paracetamol and ASS. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional information:
The Analgesics market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Over-the-counter analgesics (e.g. Aspirin and Paracetamol)
Natural and synthetic agents
In the form of pills, capsules, gels and ointments

Prescription medicines
Homeopathic remedies
Anesthetics

The Analgesics market in Saudi Arabia has experienced significant growth in recent years, driven by changing customer preferences and local special circumstances.

Customer preferences: Customers in Saudi Arabia have shown a growing preference for over-the-counter analgesics, as they provide quick and convenient relief from pain and discomfort. This preference is driven by the increasing awareness and acceptance of self-medication among consumers. Additionally, the rising prevalence of chronic diseases and the aging population have also contributed to the demand for analgesics in the country.

Trends in the market: One of the key trends in the Analgesics market in Saudi Arabia is the shift towards natural and herbal remedies. Consumers are becoming more conscious about the potential side effects of synthetic drugs and are seeking alternative options. This has led to a rise in the demand for natural analgesics, such as herbal extracts and essential oils. Manufacturers are responding to this trend by introducing a wide range of natural analgesic products to cater to the evolving needs of the customers.Another trend in the market is the increasing availability of analgesics through online channels. E-commerce platforms have gained popularity in Saudi Arabia, providing consumers with easy access to a wide range of products, including analgesics. This has significantly contributed to the growth of the market, as it offers convenience and competitive pricing to the customers.

Local special circumstances: Saudi Arabia has a high prevalence of chronic diseases, such as diabetes, cardiovascular diseases, and musculoskeletal disorders. These conditions often result in chronic pain, leading to a higher demand for analgesics. The government has taken initiatives to improve healthcare infrastructure and promote preventive healthcare measures, which has further fueled the demand for analgesics in the country.

Underlying macroeconomic factors: The growing population and increasing disposable income in Saudi Arabia have played a significant role in the development of the Analgesics market. As the population continues to grow, so does the demand for healthcare products, including analgesics. Additionally, the rising disposable income has enabled consumers to afford and access a wider range of analgesic products, further driving market growth.In conclusion, the Analgesics market in Saudi Arabia is witnessing growth due to changing customer preferences, including a shift towards natural remedies and increased availability through online channels. The high prevalence of chronic diseases and the government's focus on improving healthcare infrastructure have also contributed to the market's development. The growing population and increasing disposable income in Saudi Arabia are underlying macroeconomic factors that have further fueled the market's growth.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.